The blood cancer drug market is experiencing significant growth, driven by advancements in cancer treatment, increased awareness of blood cancer types, and a surge in demand for more effective therapies. Blood cancers, including leukemia, lymphoma, and myeloma, represent a major area of concern in oncology, and the development of drugs specifically targeting these cancers is pivotal...